Key terms

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CLSD news

Apr 16 7:32am ET Clearside Biomedical Welcomes Anthony Gibney to Board by TipRanks Apr 16 7:14am ET Clearside Biomedical appoints Gibney to board of directors by TipRanks Mar 18 7:07am ET Clearside Biomedical appoints Chong as Chief Medical Officer by TipRanks Mar 14 6:27am ET Clearside Biomedical: Strong Buy Rating on Robust Financials and Clinical Trial Progress by TipRanks Mar 14 2:01am ET Navigating a Regulatory Maze: Clearside Biomedical’s Challenge with Global Compliance and Anti-Corruption Laws by TipRanks Mar 13 6:30am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR) and Clearside Biomedical (CLSD) by TipRanks Mar 13 6:17am ET Buy Rating Affirmed for Clearside Biomedical on Innovative Treatments and Strong Financials by TipRanks Mar 13 12:30am ET Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (CLSD) and Prelude Therapeutics (PRLD) by TipRanks Mar 06 11:25am ET These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts by TipRanks Feb 09 5:13am ET Clearside Biomedical Announces Registered Direct Offering Pricing by TipRanks Feb 09 5:13am ET Clearside Biomedical Launches $15M Direct Offering by TipRanks Feb 07 8:17am ET Clearside to sell 11.11M shares at $1.35 in registered direct offering by TipRanks Jan 22 1:31pm ET Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), Vor Biopharma (VOR) and Clearside Biomedical (CLSD) by TipRanks

No recent press releases are available for CLSD

CLSD Financials

1-year income & revenue

Key terms

CLSD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CLSD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming